Searched for
TEVA CANADA LTD.
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...- Canada faces pain medicine shortage and here’s what can you doCanada is grappling with a nationwide shortage of prescription pain medications containing acetaminophen with codeine or oxycodone, impacti...
- Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and WegovyBiocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canad...
- Marksans Pharma acquires Teva's manufacturing site in GoaThe manufacturing site is spread across 47,597 sq meters and has approvals to manufacture products from EU, Health Canada and Japanese Heal...
- DRL's foray into medical cannabis to prompt others' entryIn December, global drug major Pfizer announced its acquisition of Arena Pharma, a medical cannabis company, for $6.7 billion. In May last ...
- New toxic drug impurities detected in some heart pills in USThe impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials he...
- What spooked Sun Pharma stock in Monday’s tradeA total of 93 per cent of revenue of Sun Pharma’s US unit comes from US operations.
- DRL, IPCA Laboratories products come under Canadian government scannerFDA recently pointed out as many as 9 procedural deviations in manufacturing plant belonging to Dr Reddy's Laboratories in Srikakulam distr...
- Venus Remedies ties up with Israel's Teva for anti-cancer drugChandigarh based Pharma major has entered into agreement with Israel-based generic drug maker Teva to sell anti- cancer drug in Canadian ma...
- Sun Pharma-Ranbaxy deal: We will guide Ranbaxy, says Dilip ShanghviShanghvi started his entrepreneurial dreams with a loan of Rs 10,000 from his father. It’s that same instinct that’s needed at Ranbaxy now,...
- Natco inks agreement with Mylan for CopaxoneHome grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...
- Here's someone who bet on India 12 years backHis UK colleagues were bemused by his choice, but Brian Tempest saw big potential in India.
- Lupin wins Altace patent case in USIndia’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales ...
- Glenmark gets nod to sell Zofran generic in USGlenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
- Indian drug cos prepare a peptide mixAs blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
- Local cos line up for Merck unitThe bidding process for the generics business of German pharmaceutical corporation Merck is set to begin in a few days. The advisors to Mer...
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
Load More
